Pregnancy and immunomodulatory therapy in multiple sclerosis patients;"Andere umstände": Schwangerschaft und immunmodulatorische therapie bei multipler sklerose

Nervenarzt

Volumn 77, Issue 6, 2006, Pages 663-670

  Hoffmann, L A ^a   Kumpfel T ^a   Heer, I ^a   Hohlfeld, R ^a  

^a LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

Author keywords

Immunomodulatory treatment; Multiple Sclerosis; Pregnancy

Indexed keywords

AZATHIOPRINE; BETA INTERFERON; DEXAMETHASONE; GLATIRAMER; IMMUNOGLOBULIN; IMMUNOMODULATING AGENT; METHYLPREDNISOLONE; MITOXANTRONE; PREDNISOLONE; PREDNISONE;

AMENORRHEA; CONGENITAL MALFORMATION; CONTRACEPTION; DYSMENORRHEA; FEMALE INFERTILITY; FERTILIZATION IN VITRO; GENOTOXICITY; HUMAN; IMMUNOMODULATION; INCIDENCE; MALE SEXUAL DYSFUNCTION; MENINGOCELE; MENSTRUATION DISORDER; MULTIPLE SCLEROSIS; OVARY DISEASE; PREGNANCY; REVIEW; RISK FACTOR; SPONTANEOUS ABORTION; TERATOGENICITY; TREATMENT CONTRAINDICATION;

FEMALE; HUMANS; IMMUNOLOGIC FACTORS; MULTIPLE SCLEROSIS; PHYSICIAN'S PRACTICE PATTERNS; PRACTICE GUIDELINES; PRACTICE GUIDELINES AS TOPIC; PREGNANCY; PREGNANCY COMPLICATIONS;

EID: 33746399382     PISSN: 00282804     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00115-006-2053-7     Document Type: Review

References (45)

1. Abramsky O (1994) Pregnancy and multiple sclerosis. Ann Neurol 36: S38-S41
2. Achiron A, Kishner I, Dolev M et al. (2004) Effect of intravenous immunoglobulin treatment on pregnancy and postpartum-related relapses in multiple sclerosis. J Neurol 251: 1133-1137
3. Alonso A, Jick SS, Olek MJ et al. (2005) Recent use of oral contraceptives and the risk of multiple sclerosis. Arch Neurol 62: 1362-1365
4. Bader AM, Hunt CO, Datta S et al. (1988) Anesthesia for the obstetric patient with multiple sclerosis. J Clin Anesth 1: 21-24
5. Birk K, Ford C, Smeltzer S et al. (1990) The clinical course of multiple sclerosis during pregnancy and the puerperium. Arch Neurol 47: 738-742
6. Birk K, Rudick R (1986) Pregnancy and multiple sclerosis. Arch Neurol 43: 719-726
7. Boskovic R, Wide R, Wolpin J et al. (2005) The reproductive effects of beta interferon therapy in pregnancy: a longitudinal cohort. Neurology 65: 807-811
8. Briggs G, Freeman R (1999) Drugs in pregnancy and lactation: a reference guide to fetal and neonatal risk. Williams & Wilkins, Baltimore
9. Confavreux C (2004) Intravenous immunoglobulins, pregnancy and multiple sclerosis. J Neurol 251: 1138-1139
10. Confavreux C, Hutchinson M, Hours M et al. (1999) [Multiple sclerosis and pregnancy: clinical issues]. Rev Neurol (Paris) 155: 186-191
11. Confavreux C, Hutchinson M, Hours MM et al. (1998) Rate of pregnancy-related relapse in multiple sclerosis. Pregnancy in Multiple Sclerosis Group. N Engl J Med 339: 285-291
12. Coyle PK, Johnson K, Pardo L et al. (2003) Pregnancy outcomes in patients with multiple sclerosis treated with glatiramer acetate (Copaxone). Neurology 60(Suppl 1): A60
13. Crawford JS (1983) Epidural analgesia for patients with chronic neurological disease. Anesth Analg 62: 621-622
14. Greenberger PA, Odeh YK, Frederiksen MC et al. (1993) Pharmacokinetics of prednisolone transfer to breast milk. Clin Pharmacol Ther 53: 324-328
15. Haas J (2000) High dose IVIG in the post partum period for prevention of exacerbations in MS. Mult Scler 6(Suppl2): S18-S20
16. Haas J, Hommes OR, Bauer M (2005) Multiple Sclerosis: management during pregnancy. GAMPP Study Group, European Charcot Foundation, Octapharma GnmH Poster ECTRIMS 2005
17. Hernan MA, Hohol MJ, Olek MJ et al. (2000) Oral contraceptives and the incidence of multiple sclerosis. Neurology 55: 848-854
18. Jones RM, Healy TE (1980) Anaesthesia and demyelinating disease. Anaesthesia 35: 879-884
19. Korn-Lubetzki I, Kahana E, Cooper G et al. (1984) Activity of multiple sclerosis during pregnancy and puerperium. Ann Neurol 16: 229-231
20. Laplaud DA, LEBPMTWS (2005) Multiple Sclerosis relapse rate increasing after treatment for in-vitro fertilisation. Poster ECTRIMS 2005
21. Mariotti V, Marconi AM, Pardi G (2004) Undesired effects of steroids during pregnancy. J Matern Fetal Neonatal Med 16(Suppl 2): 5
22. Millar JH, Allison RS, Cheeseman EA et al. (1959) Pregnancy as a factor influencing relapse in disseminated sclerosis. Brain 82: 417-426
23. Mueller BA, Zhang J, Critchlow CW (2002) Birth outcomes and need for hospitalization after delivery among women with multiple sclerosis. Am J Obstet Gynecol 186: 446-452
24. Nelson LM, Franklin GM, Jones MC (1988) Risk of multiple sclerosis exacerbation during pregnancy and breast-feeding. JAMA 259: 3441-3443
25. Orvieto R, Achiron R, Rotstein Z et al. (1999) Pregnancy and multiple sclerosis: a 2-year experience. Eur J Obstet Gynecol Reprod Biol 82: 191-194
26. Ostensen M, Villiger PM (2002) Immunology of pregnancy-pregnancy as a remission inducing agent in rheumatoid arthritis. Transpl Immunol 9: 155-160
27. Park-Wyllie L, Mazzotta P, Pastuszak A et al. (2000) Birth defects after maternal exposure to corticosteroids: prospective cohort study and meta-analysis of epidemiological studies. Teratology 62: 385-392
28. Perlas A, Chan VW (2005) Neuraxial anesthesia and multiple sclerosis. Can J Anaesth 52: 454-458
29. Petri M (2003) Immunosuppressive drug use in pregnancy. Autoimmunity 36: 51-56
30. Pinsky L, Di George AM (1965) Cleft palate in the mouse: a teratogenic index of glucocortocoid potency. Science 147: 402-403
31. Poser S, Poser W (1985) Activity of multiple sclerosis during pregnancy and puerperium. Ann Neurol 18: 101
32. Poser S, Raun NE, Wikstrom J et al. (1979) Pregnancy, oral contraceptives and multiple sclerosis. Acta Neurol Scand 59: 108-118
33. Rieckmann P, Toyka KV, Bassetti C et al. (2004) Escalating immunotherapy of multiple sclerosis-new aspects and practical application. J Neurol 251: 1329-1339
34. Roullet E, Verdier-Taillefer MH, Amarenco P et al. (1993) Pregnancy and multiple sclerosis: a longitudinal study of 125 remittent patients. J Neurol Neurosurg Psychiatry 56: 1062-1065
35. Saarikoski S, Seppala M (1973) Immunosuppression during pregnancy: transmission of azathioprine and its metabolites from the mother to the fetus. Am J Obstet Gynecol 115: 1100-1106
36. Sadovnick AD, Eisen K, Hashimoto SA et al. (1994) Pregnancy and multiple sclerosis. A prospective study. Arch Neurol 51: 1120-1124
37. Salemi G, Callari G, Gammino M et al. (2004) The relapse rate of multiple sclerosis changes during pregnancy: a cohort study. Acta Neurol Scand 110: 23-26
38. Sandberg-Wollheim M, Frank D, Goodwin TM et al. (2005) Pregnancy outcomes during treatment with interferon beta-1a in patients with multiple sclerosis. Neurology 65: 802-806
39. Thompson DS, Nelson LM, Burns A et al. (1986) The effects of pregnancy in multiple sclerosis: a retrospective study. Neurology 36: 1097-1099
40. Tillmann AJ (1950) The effect of pregnancy on multiple sclerosis and its management. Res Publ Assoc Res Nerv Ment Dis 28: 548-582
41. van Walderveen MA, Tas MW, Barkhof F et al. (1994) Magnetic resonance evaluation of disease activity during pregnancy in multiple sclerosis. Neurology 44: 327-329
42. Vukusic S, Hutchinson M, Hours M et al. (2004) Pregnancy and multiple sclerosis (the PRIMS study): clinical predictors of post-partum relapse. Brain 127: 1353-1360
43. Weinshenker BG, Hader W, Carriere W et al. (1989) The influence of pregnancy on disability from multiple sclerosis: a population-based study in Middlesex County, Ontario. Neurology 39: 1438-1440
44. Whitaker JN (1998) Effects of pregnancy and delivery on disease activity in multiple sclerosis. N Engl J Med 339: 339-340
45. Worthington J, Jones R, Crawford M et al. (1994) Pregnancy and multiple sclerosis - a 3-year prospective study. J Neurol 241: 228-233